Atria Investments’s Medicines Co MDCO Stock Holding History

Atria Investments’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,856	Closed	-$297K	–	927
2017 Q4	$297K	Buy	+10,856	New	+$334K	0.01%	649

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Atria Investments's MDCO Position: Q1 2018 in Review

Atria Investments sold out of Medicines Co (MDCO) in Q1 2018, closing a stake of 10,856 shares — an estimated $297K sold.

Atria Investments first reported a position in MDCO in Q4 2017 and held it in 1 quarter. The position peaked at $297K in Q4 2017. 190 funds tracked by Wall St. Rank hold MDCO as of Q1 2018.

Atria Investments reported no remaining Medicines Co position as of Q1 2018 after selling out during the quarter.
Atria Investments sold 10,856 Medicines Co shares in Q1 2018, an estimated $297K.
Atria Investments first reported a position in Medicines Co in Q4 2017 and held it in 1 quarter.
Atria Investments's Medicines Co position peaked at $297K in Q4 2017.
190 funds tracked by Wall St. Rank held Medicines Co as of Q1 2018.

Based on Atria Investments's 13F filing for Q1 2018, filed 30 Apr 2018.